Financial Year |
March 31 2023 |
Monetary Funds |
269,644,910.15 |
Held-for-trading Financial Assets |
66,184,271.08 |
Notes Receivable |
-- |
Accounts Receivable |
390,377,646.63 |
Advances to Suppliers |
2,369,642.02 |
Other Receivables |
47,413,435.80 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
55,558,674.86 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,635,792.66 |
Total Current Assets |
855,167,337.68 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
42,160,983.04 |
Investment Properties |
233,088,178.70 |
Fixed Assetes |
1,332,067,753.65 |
Under-construction Projects |
21,597,527.70 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
46,910,861.50 |
R&D expenses |
-- |
Goodwill |
172,373,054.84 |
Long-Term Deferred and Prepaid Expenses |
8,211,439.11 |
Deferred Income Tax Assets |
6,990,726.69 |
Other Non-Current Assets |
114,393,041.62 |
Sub-Total of Non-Current Assets |
2,029,132,256.43 |
Total Assets |
2,884,299,594.11 |
Short-Term Loans |
15,320,627.41 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
140,603,895.28 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
6,429,132.62 |
Taxes Payable |
17,497,969.10 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
7,773,954.03 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
15,744,828.42 |
Other Current Liabilities |
20,182,152.60 |
Sub-Total of Current Liabilities |
255,797,215.48 |
Long-term Loans |
94,747,287.46 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
9,183,463.73 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
129,897,852.47 |
Total Liabilities |
385,695,067.95 |
Paid-In Capital(Or Share Stock) |
1,898,148,679.00 |
Capital Surplus |
410,311,537.44 |
Surplus Reserve |
68,875,699.35 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
34,392,142.99 |
Minority Stockholder's Interest |
85,242,574.81 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,413,361,951.35 |
Owner's Equity(Stockholder's Equity) |
2,498,604,526.16 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,884,299,594.11 |